Clinical Trial

Study of CM313(SC) Injection in Subjects With Relapsed/Refractory Aplastic Anemia

Name: Study of CM313(SC) Injection in Subjects With Relapsed/Refractory Aplastic Anemia — clinical trial record (NCT06791824)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

This is a randomized, open-label, phase IB/II clinical study to evaluate the safety, tolerability and preliminary efficacy of CM313(SC) injection in patients with relapsed/refractory aplastic anemia

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-01-19.

Trial Details

NCT Number	NCT06791824
Lead Sponsor	Keymed Biosciences Co.Ltd
Conditions	Aplastic Anemia
Enrollment	125 participants
Start Date	2025-03
Primary Completion	2027-12 (estimated)
Study Completion	2027-12 (estimated)
Updated on ClinicalTrials.gov	2025-02-18